233 related articles for article (PubMed ID: 20395332)
1. Nanobodies as tools for in vivo imaging of specific immune cell types.
De Groeve K; Deschacht N; De Koninck C; Caveliers V; Lahoutte T; Devoogdt N; Muyldermans S; De Baetselier P; Raes G
J Nucl Med; 2010 May; 51(5):782-9. PubMed ID: 20395332
[TBL] [Abstract][Full Text] [Related]
2. In vitro analysis and in vivo tumor targeting of a humanized, grafted nanobody in mice using pinhole SPECT/micro-CT.
Vaneycken I; Govaert J; Vincke C; Caveliers V; Lahoutte T; De Baetselier P; Raes G; Bossuyt A; Muyldermans S; Devoogdt N
J Nucl Med; 2010 Jul; 51(7):1099-106. PubMed ID: 20554727
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT.
Gainkam LO; Huang L; Caveliers V; Keyaerts M; Hernot S; Vaneycken I; Vanhove C; Revets H; De Baetselier P; Lahoutte T
J Nucl Med; 2008 May; 49(5):788-95. PubMed ID: 18413403
[TBL] [Abstract][Full Text] [Related]
4. Nanobody-based targeting of the macrophage mannose receptor for effective in vivo imaging of tumor-associated macrophages.
Movahedi K; Schoonooghe S; Laoui D; Houbracken I; Waelput W; Breckpot K; Bouwens L; Lahoutte T; De Baetselier P; Raes G; Devoogdt N; Van Ginderachter JA
Cancer Res; 2012 Aug; 72(16):4165-77. PubMed ID: 22719068
[TBL] [Abstract][Full Text] [Related]
5. Imaging of Glioblastoma Tumor-Associated Myeloid Cells Using Nanobodies Targeting Signal Regulatory Protein Alpha.
De Vlaminck K; Romão E; Puttemans J; Pombo Antunes AR; Kancheva D; Scheyltjens I; Van Ginderachter JA; Muyldermans S; Devoogdt N; Movahedi K; Raes G
Front Immunol; 2021; 12():777524. PubMed ID: 34917090
[TBL] [Abstract][Full Text] [Related]
6. Development and evaluation of nanobody tracers for noninvasive nuclear imaging of the immune-checkpoint TIGIT.
Zeven K; De Groof TWM; Ceuppens H; Awad RM; Ertveldt T; de Mey W; Meeus F; Raes G; Breckpot K; Devoogdt N
Front Immunol; 2023; 14():1268900. PubMed ID: 37799715
[TBL] [Abstract][Full Text] [Related]
7. Identification of Nanobodies against the Acute Myeloid Leukemia Marker CD33.
Romão E; Krasniqi A; Maes L; Vandenbrande C; Sterckx YG; Stijlemans B; Vincke C; Devoogdt N; Muyldermans S
Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31906437
[TBL] [Abstract][Full Text] [Related]
8. Non-Invasive Imaging of Amyloid Deposits in a Mouse Model of AGel Using
Verhelle A; Van Overbeke W; Peleman C; De Smet R; Zwaenepoel O; Lahoutte T; Van Dorpe J; Devoogdt N; Gettemans J
Mol Imaging Biol; 2016 Dec; 18(6):887-897. PubMed ID: 27130233
[TBL] [Abstract][Full Text] [Related]
9. Preclinical screening of anti-HER2 nanobodies for molecular imaging of breast cancer.
Vaneycken I; Devoogdt N; Van Gassen N; Vincke C; Xavier C; Wernery U; Muyldermans S; Lahoutte T; Caveliers V
FASEB J; 2011 Jul; 25(7):2433-46. PubMed ID: 21478264
[TBL] [Abstract][Full Text] [Related]
10. Streamlined method for parallel identification of single domain antibodies to membrane receptors on whole cells.
Rossotti M; Tabares S; Alfaya L; Leizagoyen C; Moron G; González-Sapienza G
Biochim Biophys Acta; 2015 Jul; 1850(7):1397-404. PubMed ID: 25819371
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive Imaging of the Immune Checkpoint LAG-3 Using Nanobodies, from Development to Pre-Clinical Use.
Lecocq Q; Zeven K; De Vlaeminck Y; Martens S; Massa S; Goyvaerts C; Raes G; Keyaerts M; Breckpot K; Devoogdt N
Biomolecules; 2019 Sep; 9(10):. PubMed ID: 31569553
[TBL] [Abstract][Full Text] [Related]
12. A novel multivalent (99m)Tc-labeled EG2-C4bpα antibody for targeting the epidermal growth factor receptor in tumor xenografts.
Li C; Zhang Y; Wang L; Feng H; Xia X; Ma J; Yuan H; Gao B; Lan X
Nucl Med Biol; 2015 Jun; 42(6):547-54. PubMed ID: 25779037
[TBL] [Abstract][Full Text] [Related]
13. Molecular imaging with macrophage CRIg-targeting nanobodies for early and preclinical diagnosis in a mouse model of rheumatoid arthritis.
Zheng F; Put S; Bouwens L; Lahoutte T; Matthys P; Muyldermans S; De Baetselier P; Devoogdt N; Raes G; Schoonooghe S
J Nucl Med; 2014 May; 55(5):824-9. PubMed ID: 24686780
[TBL] [Abstract][Full Text] [Related]
14. Molecular Imaging with Kupffer Cell-Targeting Nanobodies for Diagnosis and Prognosis in Mouse Models of Liver Pathogenesis.
Zheng F; Sparkes A; De Baetselier P; Schoonooghe S; Stijlemans B; Muyldermans S; Flamand V; Van Ginderachter JA; Devoogdt N; Raes G; Beschin A
Mol Imaging Biol; 2017 Feb; 19(1):49-58. PubMed ID: 27339464
[TBL] [Abstract][Full Text] [Related]
15. Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics.
Bannas P; Hambach J; Koch-Nolte F
Front Immunol; 2017; 8():1603. PubMed ID: 29213270
[TBL] [Abstract][Full Text] [Related]
16. General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold.
Vincke C; Loris R; Saerens D; Martinez-Rodriguez S; Muyldermans S; Conrath K
J Biol Chem; 2009 Jan; 284(5):3273-3284. PubMed ID: 19010777
[TBL] [Abstract][Full Text] [Related]
17. Localization, mechanism and reduction of renal retention of technetium-99m labeled epidermal growth factor receptor-specific nanobody in mice.
Gainkam LO; Caveliers V; Devoogdt N; Vanhove C; Xavier C; Boerman O; Muyldermans S; Bossuyt A; Lahoutte T
Contrast Media Mol Imaging; 2011; 6(2):85-92. PubMed ID: 20936711
[TBL] [Abstract][Full Text] [Related]
18. (99m)Tc-labeled SWL specific peptide for targeting EphA2 receptor.
Liu Y; Lan X; Wu T; Lang J; Jin X; Sun X; Wen Q; An R
Nucl Med Biol; 2014 Jul; 41(6):450-6. PubMed ID: 24768147
[TBL] [Abstract][Full Text] [Related]
19. Using microdialysis to analyse the passage of monovalent nanobodies through the blood-brain barrier.
Caljon G; Caveliers V; Lahoutte T; Stijlemans B; Ghassabeh GH; Van Den Abbeele J; Smolders I; De Baetselier P; Michotte Y; Muyldermans S; Magez S; Clinckers R
Br J Pharmacol; 2012 Apr; 165(7):2341-53. PubMed ID: 22013955
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
